Meiji Yasuda Life Insurance’s Quest Diagnostics DGX Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,826	Closed	-$234K	–	330
2021 Q1	$234K	Buy	+1,826	New	+$225K	﹤0.01%	307
2020 Q2	–	Sell	-3,409	Closed	-$274K	–	288
2020 Q1	$274K	Sell	3,409 -2,296	-40%	-$238K	0.05%	233
2019 Q4	$609K	Sell	5,705 -120	-2%	-$12.5K	0.08%	202
2019 Q3	$623K	Buy	5,825 +1,030	+21%	+$106K	0.09%	191
2019 Q2	$488K	Buy	+4,795	New	+$461K	0.07%	230
2019 Q1	–	Sell	-3,300	Closed	-$275K	–	308
2018 Q4	$275K	Buy	+3,300	New	+$309K	0.04%	295
2014 Q2	–	Sell	-4,430	Closed	-$257K	–	375
2014 Q1	$257K	Sell	4,430 -995	-18%	-$53.3K	0.04%	317
2013 Q4	$290K	Buy	+5,425	New	+$322K	0.05%	312

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Meiji Yasuda Life Insurance's DGX Position: Q2 2021 in Review

Meiji Yasuda Life Insurance sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 1,826 shares — an estimated $234K sold.

Meiji Yasuda Life Insurance first reported a position in DGX in Q4 2013 and held it in 8 quarters. The position peaked at $623K in Q3 2019. 815 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

Meiji Yasuda Life Insurance reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
Meiji Yasuda Life Insurance sold 1,826 Quest Diagnostics shares in Q2 2021, an estimated $234K.
Meiji Yasuda Life Insurance first reported a position in Quest Diagnostics in Q4 2013 and held it in 8 quarters.
Meiji Yasuda Life Insurance's Quest Diagnostics position peaked at $623K in Q3 2019.
815 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on Meiji Yasuda Life Insurance's 13F filing for Q2 2021, filed 16 Aug 2021.